This paper might be of interest to the BIT investors [1] as it is an independent (if biased) assessment of BIT225. Two things were very interesting.
1. BIT225 is thought to be too toxic to use. Quoting from the paper
Two acylguanidine-containing compounds, HMA (Fig. 1A) and BIT-225 (Fig. 1B), are reported to inhibit HIV-1 replication; however, both display substantial in vitro toxicity, particularly to T cells (5, 6, 34, 35). We therefore sought to design an acylguanidine-based derivative with a reduced cytotoxic component. We observed that the heterocyclic amino-pyrazine core of HMA resembles the heterocyclic core of methotrexate, which is also cytotoxic (46), and speculated that the high nitrogen density in these cores might be a cause.
2. HIV-1 resistance mutations to acylguanidines can be easily be isolated. The highly conserved structure of VPU does not seem to prevent HIV-1 resistance mutations arising in this protein.
1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044834/
- Forums
- ASX - By Stock
- BIT Science Discussion
This paper might be of interest to the BIT investors [1] as it...
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $41.50M |
Open | High | Low | Value | Volume |
4.4¢ | 4.7¢ | 4.4¢ | $31.64K | 708.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 259000 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 17361 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 259000 | 0.045 |
1 | 200000 | 0.044 |
4 | 438255 | 0.043 |
4 | 342000 | 0.042 |
4 | 287000 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 17361 | 1 |
0.047 | 225000 | 2 |
0.048 | 308915 | 1 |
0.050 | 21000 | 1 |
0.051 | 96225 | 3 |
Last trade - 14.10pm 21/06/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online